Clinical Trials Directory

Explore 66,650 clinical trials worldwide

Showing 52401-52450 of 66,650 trials

Active filters:Status: Recruiting

Clinical Trials (66,650)

NCT05155280
Serotonin Role on Brain Circuits Involved in Food Avoidance in Anorexia Nervosa
NARecruiting
75 participants
Started: Dec 10, 2021 · Completed: Aug 31, 2025
1 condition1 sponsor1 location
NCT05192824
Effects of Different Designs of Orthokeratology Lens on Myopia Control and Visual Quality
NARecruiting
200 participants
Started: Dec 10, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT04999332
Perioperative Leucovorin, Oxaliplatin, Docetaxel and S-1 (LOTS) For Locally Advanced Gastric or Gastroesophageal Junction Cancer
PHASE2Recruiting
58 participants
Started: Dec 10, 2021 · Completed: Dec 31, 2025
4 conditions5 sponsors4 locations
NCT05652933
Optimizing Acute Ischemic Stroke Diagnostics Using Artificial Intelligence
N/ARecruiting
300 participants
Started: Dec 10, 2021 · Completed: Dec 31, 2025
1 condition4 sponsors3 locations
NCT05000892
Neoadjuvant Sintilimab in Combination With Carboplatin and Nab-paclitaxel in Untreated Salivary Gland Malignant Neoplasms
PHASE2Recruiting
15 participants
Started: Dec 10, 2021 · Completed: Oct 1, 2027
2 conditions1 sponsor1 location
NCT04697810
Namodenoson in the Treatment of Non-Alcoholic Steatohepatitis (NASH)
PHASE2Recruiting
114 participants
Started: Dec 10, 2021 · Completed: Oct 15, 2025
1 condition1 sponsor24 locations
NCT05087745
A Clinical Study on TIL for the Treatment of Advanced Solid Tumors
EARLY_PHASE1Recruiting
50 participants
Started: Dec 10, 2021 · Completed: Dec 10, 2025
4 conditions2 sponsors1 location
NCT06564662
Rapid-Response EEG in Children With Suspected Status Epilepticus
N/ARecruiting
60 participants
Started: Dec 9, 2021 · Completed: Dec 8, 2026
2 conditions1 sponsor1 location
NCT04977375
Trial of Anti-PD-1 Immunotherapy and Stereotactic Radiation in Patients With Recurrent Glioblastoma
PHASE1/PHASE2Recruiting
10 participants
Started: Dec 9, 2021 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT05233982
MITO 35a: Olaparib Maintenance Therapy in Newly Diagnosed BRCA Wild-type Advanced Ovarian, Fallopian Tube and Primitive Peritoneal Cancer
PHASE2Recruiting
200 participants
Started: Dec 9, 2021 · Completed: Jan 31, 2026
1 condition1 sponsor5 locations
NCT05155189
A Study to Evaluate Safety and Efficacy of Armored CAR-T Cell Injection C-CAR031 in Advanced Hepatocellular Carcinoma
PHASE1Recruiting
44 participants
Started: Dec 9, 2021 · Completed: May 31, 2041
1 condition1 sponsor2 locations
NCT06322290
Epidemiological Study on Invasive Bacterial Diseases
N/ARecruiting
5,000 participants
Started: Dec 9, 2021 · Completed: Mar 30, 2032
1 condition1 sponsor38 locations
NCT05197270
4D-150 in Patients With Neovascular (Wet) Age-Related Macular Degeneration
PHASE1/PHASE2Recruiting
215 participants
Started: Dec 9, 2021 · Completed: Jan 31, 2031
1 condition1 sponsor24 locations
NCT05171478
Full-Field Optical Coherence Tomography (FFOCT) for Evaluation of Bronchoscopic Small Biopsy Specimens
N/ARecruiting
20 participants
Started: Dec 9, 2021 · Completed: Dec 8, 2025
2 conditions1 sponsor1 location
NCT05169970
A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer
PHASE2Recruiting
215 participants
Started: Dec 9, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor7 locations
NCT05183906
Evaluation of Next-Generation Sequencing-based Metabarcoding Versus Culturing for Microbiological Assessment in Infectious Keratitis
N/ARecruiting
100 participants
Started: Dec 9, 2021 · Completed: Jun 1, 2024
1 condition1 sponsor1 location
NCT04499131
Impact of Different Doses and Routes of Exogenous Progesterone Administration on Endometrial Receptivity Parameters
PHASE4Recruiting
108 participants
Started: Dec 9, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04969471
NATURE (EnVast As an Adjunct PPCI in Subjects Presenting with STEMI)
NARecruiting
148 participants
Started: Dec 9, 2021 · Completed: Sep 30, 2026
1 condition1 sponsor1 location
NCT04702256
Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF
PHASE3Recruiting
196 participants
Started: Dec 9, 2021 · Completed: Dec 31, 2031
2 conditions2 sponsors1 location
NCT04866329
Female Fertility, Environmental Agents and Stress Oxidant
N/ARecruiting
500 participants
Started: Dec 8, 2021 · Completed: Dec 31, 2027
1 condition1 sponsor1 location
NCT05274230
Sustaining Remission From PTSD Using Tuned Vibroacoustic Stimulation (TVS) Following MDMA-Assisted Psychotherapy
NARecruiting
200 participants
Started: Dec 8, 2021 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05000645
Grocery Delivery and Healthy Weight Gain Among Low-income Pregnant Young Women
NARecruiting
570 participants
Started: Dec 8, 2021 · Completed: Oct 31, 2027
2 conditions2 sponsors1 location
NCT04982367
Acoart SCB SFA: Sirolimus Coated Balloon Catheter in the Treatment of Femoropopliteal Artery Stenosis
NARecruiting
166 participants
Started: Dec 8, 2021 · Completed: Jul 31, 2024
1 condition1 sponsor1 location
NCT04150198
MECHANISMS OF NEURONAL RESILIENCE IN ALZHEIMER'S DISEASE AND ITS FOCAL VARIANTS: A PET/MR STUDY
NARecruiting
45 participants
Started: Dec 8, 2021 · Completed: Dec 31, 2026
2 conditions2 sponsors2 locations
NCT05005897
Early Infant Micronutrition and Development
PHASE2/PHASE3Recruiting
600 participants
Started: Dec 8, 2021 · Completed: Oct 15, 2029
1 condition4 sponsors1 location
NCT04774913
Invest-CTO PCI Trial
NARecruiting
200 participants
Started: Dec 8, 2021 · Completed: Oct 31, 2026
4 conditions2 sponsors5 locations
NCT05216432
First-in-Human Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, as a Single Agent in Patients With Advanced Solid Tumors and in Combination With Endocrine Therapy +/- a CDK4/6 or CDK4 Inhibitor in Patients With Advanced Solid Tumors or Advanced Breast Cancer
PHASE1Recruiting
930 participants
Started: Dec 8, 2021 · Completed: Apr 30, 2027
7 conditions1 sponsor37 locations
NCT04733950
Cochlear Implanted Listening Effort and Hearing Attention
NARecruiting
170 participants
Started: Dec 8, 2021 · Completed: Feb 22, 2026
1 condition1 sponsor1 location
NCT04587791
Cannabidiol in Opioid Use Disorder and Chronic Pain
EARLY_PHASE1Recruiting
40 participants
Started: Dec 8, 2021 · Completed: Mar 31, 2026
2 conditions3 sponsors1 location
NCT06290505
A Trial of Palliative Chemotherapy, Radiation and Immune Treatment for Oesophageal Cancer: PALEO Study
PHASE2Recruiting
54 participants
Started: Dec 8, 2021 · Completed: Jul 31, 2029
1 condition1 sponsor9 locations
NCT05053854
PARP Inhibitor With 177Lu-DOTA-Octreotate PRRT in Patients With Neuroendocrine Tumours
PHASE1Recruiting
24 participants
Started: Dec 8, 2021 · Completed: Jun 30, 2029
1 condition1 sponsor1 location
NCT04987957
Effect Of Musıc Therapy On Anxıety Levels In COVID-19 Pandemıc
NARecruiting
42 participants
Started: Dec 8, 2021 · Completed: Dec 31, 2026
1 condition1 sponsor1 location
NCT05164107
Safety and Performance of a Pulsed Field Device for Global Mapping and Ablation of the Left Atrium for the Treatment of Atrial Fibrillation
NARecruiting
175 participants
Started: Dec 8, 2021 · Completed: May 31, 2027
1 condition1 sponsor1 location
NCT05028972
Hearing Impairment, Strategies and Outcomes in VA Emergency Departments
NARecruiting
1,050 participants
Started: Dec 8, 2021 · Completed: Sep 30, 2026
3 conditions2 sponsors6 locations
NCT04984967
Interest of Peripheral Venous Catheter Insertion Using a Micro-guide in Neonatology
NARecruiting
116 participants
Started: Dec 8, 2021 · Completed: Mar 31, 2025
3 conditions1 sponsor1 location
NCT04389281
X-ray Psoralen Activated Cancer Therapy in Head and Neck, Breast, Sarcoma and Melanoma
PHASE1Recruiting
20 participants
Started: Dec 8, 2021 · Completed: Mar 31, 2026
1 condition1 sponsor4 locations
NCT06286878
Pleiotropic Effects of Dapagliflozin in Patients With Acute Coronary Syndromes
PHASE2/PHASE3Recruiting
80 participants
Started: Dec 8, 2021 · Completed: Jul 30, 2025
4 conditions1 sponsor1 location
NCT05751018
Phase II Clinical Study of Pyrotinib in First-line Treatment of Primary HER2-amplified/Mutated Advanced Non-small Cell Lung Cancer
PHASE2Recruiting
45 participants
Started: Dec 8, 2021 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT06995313
Biofeedback Training for Hemianopia
NARecruiting
70 participants
Started: Dec 8, 2021 · Completed: Jul 8, 2026
2 conditions1 sponsor1 location
NCT04151472
Idebenone for the Preventive Treatment of Migraine
PHASE3Recruiting
180 participants
Started: Dec 8, 2021 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05173597
Real-world Evidence on Follitropin Delta Individual Dosing
N/ARecruiting
850 participants
Started: Dec 8, 2021 · Completed: Mar 31, 2026
2 conditions1 sponsor1 location
NCT05003895
GPC3 Targeted CAR-T Cell Therapy in Advanced GPC3 Expressing Hepatocellular Carcinoma (HCC)
PHASE1Recruiting
38 participants
Started: Dec 8, 2021 · Completed: Dec 31, 2027
3 conditions1 sponsor1 location
NCT04717674
[18F]FPIA PET/CT Imaging in Patients With Solid Tumours
PHASE2Recruiting
21 participants
Started: Dec 7, 2021 · Completed: Oct 31, 2024
2 conditions4 sponsors3 locations
NCT06490237
Coding of Speech Signals in the Human Auditory Nerve
NARecruiting
60 participants
Started: Dec 7, 2021 · Completed: Jun 7, 2027
1 condition1 sponsor1 location
NCT04702581
A Randomized Trial of Delayed Radiotherapy in Patients Low-grade Oligodendrogliomas Requiring a Treatment Other Than Surgery
PHASE3Recruiting
280 participants
Started: Dec 7, 2021 · Completed: Dec 31, 2030
3 conditions1 sponsor26 locations
NCT04982757
Accelerated TMS for Depression and OCD
NARecruiting
500 participants
Started: Dec 7, 2021 · Completed: Aug 31, 2026
2 conditions4 sponsors1 location
NCT05423028
Vitamin B12 and Dextrose for Median Nerve Hydrodissection
NARecruiting
120 participants
Started: Dec 7, 2021 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT05014139
A Study of Intravesical Enfortumab Vedotin For Treatment of Patients With Non-muscle Invasive Bladder Cancer (NMIBC)
PHASE1Recruiting
58 participants
Started: Dec 7, 2021 · Completed: May 31, 2028
5 conditions2 sponsors32 locations
NCT05153252
Timing Intervention of Morning Versus Evening Exercise
NARecruiting
128 participants
Started: Dec 7, 2021 · Completed: Mar 31, 2027
1 condition2 sponsors1 location
NCT06814925
Italian Study of Patients With Lymphoma
N/ARecruiting
1,500 participants
Started: Dec 7, 2021 · Completed: Aug 31, 2026
1 condition1 sponsor1 location